These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 7879103)

  • 1. Donor administration of PAF antagonist (TCV-309) enhances lung preservation.
    Ide S; Kawahara K; Takahashi T; Sasaki N; Shingu H; Nagayasu T; Yamamoto S; Tagawa T; Tomita M
    Transplant Proc; 1995 Feb; 27(1):570-3. PubMed ID: 7879103
    [No Abstract]   [Full Text] [Related]  

  • 2. Extended lung preservation with platelet-activating factor-antagonist TCV-309 in combination with prostaglandin E1.
    Qayumi AK; English JE; Duncan S; Ansley DM; Pearson B; Nikbakht-Sangari M; Sammartino C; Fradet G
    J Heart Lung Transplant; 1997 Sep; 16(9):946-55. PubMed ID: 9322146
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beneficial effect of platelet-activating factor antagonist TCV-309 on renal ischemia-reperfusion injury.
    Yin M; Kurvers HA; Buurman WA; Tangelder GJ; Booster MH; Daemen JH; Kondracki S; Kootstra G
    Transplant Proc; 1995 Feb; 27(1):774-6. PubMed ID: 7879180
    [No Abstract]   [Full Text] [Related]  

  • 4. Platelet-activating factor antagonist TCV-309 protects rat kidneys against ischemia-reperfusion injury.
    Yin M; Kurvers HA; Buurman WA; Tangelder GJ; Tiebosch AT; Daemen JH; Kootstra G
    Transplant Proc; 1995 Oct; 27(5):2844-6. PubMed ID: 7482939
    [No Abstract]   [Full Text] [Related]  

  • 5. The effect of the platelet-activating factor inhibitor TCV-309 on reperfusion injury in a canine model of ischemic lung.
    Kawahara K; Tagawa T; Takahashi T; Akamine S; Nakamura A; Yamamoto S; Muraoka S; Tomita M
    Transplantation; 1993 Jun; 55(6):1438-9. PubMed ID: 8516834
    [No Abstract]   [Full Text] [Related]  

  • 6. Combined treatment with endothelin- and PAF-antagonists reduces posttransplant lung ischemia/reperfusion injury.
    Stammberger U; Carboni GL; Hillinger S; Schneiter D; Weder W; Schmid RA
    J Heart Lung Transplant; 1999 Sep; 18(9):862-8. PubMed ID: 10528748
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The PAF antagonist TCV-309 reduces graft PMN infiltration and enhances early function of 24-hour-preserved rat kidneys with long warm ischemia.
    Yin M; Buurman WA; Daemen JW; Kootstra G
    Transplantation; 1996 May; 61(10):1443-6. PubMed ID: 8633367
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Platelet activating factor (PAF) antagonists: development of a highly potent PAF antagonist, TCV-309.
    Takatani M; Maezaki N; Imura Y; Terashita Z; Nishikawa K; Tsushima S
    Adv Prostaglandin Thromboxane Leukot Res; 1991; 21B():943-6. PubMed ID: 1825438
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of platelet activating factor antagonist, TCV309, on the relationship between electrophysiological and mechanical status during myocardial ischemia and reperfusion.
    Tamura K; Kimura Y; Tamura T; Kitashiro S; Izuoka T; Iwasaka T; Inada M
    Ann N Y Acad Sci; 1994 Jun; 723():371-4. PubMed ID: 8030887
    [No Abstract]   [Full Text] [Related]  

  • 10. Pharmacological profile of TCV-309--a potent PAF antagonist.
    Terashita Z; Takatani M; Nishikawa K
    J Lipid Mediat; 1992; 5(2):183-5. PubMed ID: 1445598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of platelet activating factor antagonist (TCV-309) on lung injury in dogs with experimentally endotoxin-induced shock.
    Okano S; Tagawa M; Urakawa N
    J Vet Med Sci; 1995 Aug; 57(4):751-3. PubMed ID: 8519912
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Platelet-activating factor antagonist TCV-309 attenuates the induction of the cytokine network in experimental endotoxemia in chimpanzees.
    Kuipers B; van der Poll T; Levi M; van Deventer SJ; ten Cate H; Imai Y; Hack CE; ten Cate JW
    J Immunol; 1994 Mar; 152(5):2438-46. PubMed ID: 8133055
    [TBL] [Abstract][Full Text] [Related]  

  • 13. TCV-309, a novel platelet activating factor antagonist, inhibits leukocyte accumulation and protects against splanchnic artery occlusion shock.
    Canale P; Squadrito F; Altavilla D; Ioculano M; Zingarelli B; Campo GM; Urna G; Sardella A; Squadrito G; Caputi AP
    Agents Actions; 1994 Oct; 42(3-4):128-34. PubMed ID: 7879698
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effects of TCV-309, a novel PAF antagonist, on circulatory shock and hematological abnormality induced by endotoxin in dogs.
    Kawamura M; Kitayoshi T; Terashita Z; Fujiwara S; Takatani M; Nishikawa K
    J Lipid Mediat Cell Signal; 1994 May; 9(3):255-65. PubMed ID: 7921785
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of platelet activating factor in cardiac dysfunction, apoptosis and nitric oxide synthase mRNA expression in the ischemic-reperfused rabbit heart.
    Loucks EB; Godin DV; Walley KR; McManus BM; Rahimian R; Granville DJ; Hong JM; Aktary FM; Qayumi AK
    Can J Cardiol; 2003 Mar; 19(3):267-74. PubMed ID: 12677282
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An arterial blood gas analysis in the canine bilateral sequential lung transplant model flushed with modified Euro-Collins solution.
    Sohn KH; Park SI; Kim DK; Song MG; Cho MW
    Transplant Proc; 1996 Jun; 28(3):1834-5. PubMed ID: 8658906
    [No Abstract]   [Full Text] [Related]  

  • 17. Allopurinol and deferoxamine improve canine lung preservation.
    Bonser RS; Fragomeni LS; Edwards BJ; Goldston E; Fischel R; Jamieson SW; Kaye MP
    Transplant Proc; 1990 Apr; 22(2):557-8. PubMed ID: 2326982
    [No Abstract]   [Full Text] [Related]  

  • 18. Platelet activating factor antagonist has a protective effect on preservation/reperfusion injury of the graft in pig liver transplantation.
    Takada Y; Boudjema K; Jaeck D; Chenard MP; Wolf P; Cinqualbre J; Yamaoka Y
    Transplant Proc; 1995 Feb; 27(1):747-8. PubMed ID: 7879169
    [No Abstract]   [Full Text] [Related]  

  • 19. Successful 12-hour lung preservation with trehalose.
    Hirata T; Yokomise H; Fukuse T; Muro K; Ono N; Inui K; Hitomi S; Wada H
    Transplant Proc; 1993 Feb; 25(1 Pt 2):1597-8. PubMed ID: 8442204
    [No Abstract]   [Full Text] [Related]  

  • 20. Platelet activating factor antagonist enhances lung preservation in a canine model of single lung allotransplantation.
    Corcoran PC; Wang Y; Katz NM; Rajan SS; Analouei AR; Foegh ML; Wallace RB
    J Thorac Cardiovasc Surg; 1992 Jul; 104(1):66-72. PubMed ID: 1614217
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.